Thienopyrimidinedinones and their use in modulation of autoimmune disease
US7393854B2 · kind B2 · utility
0Cited by
5References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2004 |
| Grant date | Jul 1, 2008 |
| Priority date | — |
| Expiry date | Jan 15, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to thienopyrimidinediones of formula (I):wherein: Processes for the preparation of compounds of formula (I), pharmaceutical compositions containing them and their use in therapy are also described and claimed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.